Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Siemens PETNET Solutions is a global leader in the manufacturing and distribution of positron emission tomography (PET) radiopharmaceuticals. The Nottingham facility, often referred to as Nottingham PETNET, is a strategic site in the United Kingdom that operates through a partnership between Siemens Healthineers and the University of Nottingham. The company functions as a specialized contract manufacturing organization (CMO), providing high-quality imaging tracers for both clinical diagnostics and pharmaceutical research. Their services include the production of standard-of-care biomarkers like FDG as well as novel tracers for oncology, neurology, and cardiology. By maintaining a robust network of cyclotrons, PETNET ensures the reliable delivery of time-sensitive radiopharmaceuticals to hospitals and research centers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nottingham PETNET.